Overview
Servet Bolukbas practices in Essen, Germany. Bolukbas is rated as an Experienced expert by MediFind in the treatment of Hyperhidrosis. Their top areas of expertise are Mesothelioma, Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Lung Transplant, and Thymectomy.
Their clinical research consists of co-authoring 118 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Hyperhidrosis.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerBolukbas isDistinguished. Learn about Lung Cancer.
- MesotheliomaBolukbas isDistinguished. Learn about Mesothelioma.
- Advanced
- Lung MetastasesBolukbas isAdvanced. Learn about Lung Metastases.
- Lung TransplantBolukbas isAdvanced. Learn about Lung Transplant.
- Non-Small Cell Lung Cancer (NSCLC)
- Pulmonary AspergillomaBolukbas isAdvanced. Learn about Pulmonary Aspergilloma.
- Experienced
- Acute PainBolukbas isExperienced. Learn about Acute Pain.
- Adult Soft Tissue SarcomaBolukbas isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AluminosisBolukbas isExperienced. Learn about Aluminosis.
- AspergillosisBolukbas isExperienced. Learn about Aspergillosis.
- Bone TumorBolukbas isExperienced. Learn about Bone Tumor.
- Bronchiolitis ObliteransBolukbas isExperienced. Learn about Bronchiolitis Obliterans.